Document:

Exhibit 10.8

 

ACAMAR PARTNERS ACQUISITION CORP.

1450 Brickell Avenue, Suite 2130

Miami, Florida 33131

 

_______, 2019

 

Acamar Partners Sponsor LLC

1450 Brickell Avenue, Suite 2130

Miami, Florida 33131

 

Enso Advisory LLC

1450 Brickell Avenue, Suite 2130

Miami, Florida 33131

 

Re: Administrative Support Agreement

 

Ladies and Gentlemen:

 

This letter agreement by and between Acamar
Partners Acquisition Corp. (the “Company”), on the one hand, and Acamar Partners Sponsor LLC (“Sponsor”)
and its affiliate, Enso Advisory LLC (“Enso”), on the other hand, dated as of the date hereof, will confirm our agreement
that, commencing on the date the securities of the Company are first listed on The Nasdaq Capital Market (the “Listing Date”),
pursuant to a Registration Statement on Form S-1 and prospectus filed with the U.S. Securities and Exchange Commission (the
“Registration Statement”) and continuing until the earlier of the consummation by the Company of an initial business
combination or the Company’s liquidation (in each case as described in the Registration Statement) (such earlier date hereinafter
referred to as the “Termination Date”):

 

(i) Enso shall make available, or cause
to be made available, to the Company, at 1450 Brickell Avenue, Suite 2130, Miami, Florida 33131 (or any successor location provided
by Enso), certain office space, administrative support, and employees of Enso as may be reasonably required by the Company, to
help with due diligence and related services in connection with the Company’s search for a target company. In exchange therefor,
the Company shall pay Enso the sum of $37,000 per month on the Listing Date and continuing monthly thereafter until the Termination
Date; provided, that no salaries or fees will be paid from this monthly amount to members of the Company’s management team;
and

 

(ii) Each of Enso and Sponsor hereby
irrevocably waives any and all right, title, interest, causes of action and claims of any kind as a result of, or arising out of,
this letter agreement (each, a “Claim”) in or to, and any and all right to seek payment of any amounts due to it out
of, the trust account established for the benefit of the public stockholders of the Company and into which substantially all of
the proceeds of the Company’s initial public offering will be deposited (the “Trust Account”) as a result of,
or arising out of, this letter agreement, and hereby irrevocably waives any Claim it may have in the future, which Claim would
reduce, encumber or otherwise adversely affect the Trust Account or any monies or other assets in the Trust Account, and further
agrees not to seek recourse, reimbursement, payment or satisfaction of any Claim against the Trust Account or any monies or other
assets in the Trust Account for any reason whatsoever.

 

This letter agreement constitutes the entire
agreement and understanding of the parties hereto in respect of its subject matter and supersedes all prior understandings, agreements,
or representations by or among the parties hereto, written or oral, to the extent they relate in any way to the subject matter
hereof or the transactions contemplated hereby.

 

This letter agreement may not be amended,
modified or waived as to any particular provision, except by a written instrument executed by the parties hereto.

 

     

     

    

 

No party hereto may assign either this letter
agreement or any of its rights, interests, or obligations hereunder without the prior written approval of the other party. Any
purported assignment in violation of this paragraph shall be void and ineffectual and shall not operate to transfer or assign any
interest or title to the purported assignee.

 

This letter agreement constitutes the entire
relationship of the parties hereto, and any litigation between the parties (whether grounded in contract, tort, statute, law or
equity) shall be governed by, construed in accordance with, and interpreted pursuant to the laws of the State of New York, without
giving effect to its choice of law principles.

 

[Signature Page Follows]

 

     

     

    

  

	 	Very truly yours,
	 	 
	 	ACAMAR PARTNERS ACQUISITION CORP.
	 	 	 
	 	By:	 
	 	 	Name: 
	 	 	Title: 

 

AGREED TO AND ACCEPTED BY:

 

ACAMAR PARTNERS SPONSOR LLC

 

	By:   	 	 
	Name:  	 	 
	Title:   	 	 

 

ENSO ADVISORY LLC

 

	By:   	 	 
	Name:  	 	 
	Title:   	 	 

 

[Signature Page to Administrative Support
Agreement]Exhibit
10.1

 

THIS
NOTE AND THE COMMON STOCK ISSUABLE UPON CONVERSION OF THIS NOTE HAVE NOT BEEN AND WILL NOT BE REGISTERED WITH THE UNITED STATES
SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE PURSUANT TO AN EXEMPTION FROM REGISTRATION PROVIDED
UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND THERULESANDREGULATIONS PROMULGATED THEREUNDER (THE "1933 ACT")

 

us
$63,000.00

 

REGEN
BIOPHARMA, INC.

8%
CONVERTIBLE REDEEMABLE NOTE DUE OCTOBER 3, 2019

 

 

FOR
VALUE RECEIVED, Regen Biopharma, Inc. (the "Company") promises to pay to the order of LG CAPITAL FUNDING, LLC and its
authorized successors and permitted assigns ("Holder"), the aggregate principal face amount of Sixty Three Thousand
Dollars (U.S. $63,000.00) on October 3, 2019 ("Maturity Date") and to pay interest on the principal amount outstanding
hereunder at the rate of 8% per annum commencing on October 3, 2018. The interest will be paid to the Holder in whose name this
Note is registered on the records of the Company regarding registration and transfers of this Note. The principal of, and interest
on, this Note are payable at 1218 Union Street, Suite #2, Brooklyn, NY 11225, initially, and if changed, last ap pearing on the
records of the Company as designated in writing by the Holder hereof from time to time. The Company will pay each interest payment
and the outstanding principal due upon this Note before or on the Maturity Date, less any amounts required by law to be deducted
or withheld, to the Holder of this Note by check or wire transfer addressed to such Holder at the last address appearing on the
records of the Company. The forwarding of such check or wire transfer shall constitute a payment of outstanding principal hereunder
and shall satisfy and discharge the liability for principal on this Note to the extent of the sum represented by such check or
wire transfer. Interest shall be payable in Common Stock (as defined below) pursuant to paragraph 4(b) herein.

This
Note is subject to the following additional provisions:

1.                 
This Note is exchangeable for an equal aggregate principal amount of Notes of
different
authorized denominations, as requested by the Holder surrendering the same.

No
service charge will be made for such registration or transfer or exchange, except that Holder shall pay any tax or other governmental
charges payable in connection therewith.

 

2.                 
The Company shall be entitled to withhold from all payments any amounts required to be withheld under applicable laws.

 

3.                 
This Note may be transferred or exchanged only in compliance with the Securities Act of 1933, as amended ("Act")
and applicable state securities laws. Any attempted transfer to a non-qualifying party shall be treated by the Company as
void. Prior to due present ment for transfer of this Note, the Company and any agent of the Company may treat the person in whose
name this Note is duly registered on the Company's records as the owner hereof for all other purposes, whether or not this Note
be overdue, and neither the Company nor any such agent shall be affected or bound by notice to the contrary. Any Holder of this
Note electing to exercise the right of conversion set forth in Section 4(a) hereof, in addition to the requirements set forth
in Section 4(a), and any prospective transferee of this Note, also is required to give the Company written confirmation that this
Note is being converted ("Notice of Conversion") in the form annexed hereto as Exhibit A. The date of
receipt (including receipt by telecopy) of such Notice of Conversion shall be the Conversion Date.

 

4.                 
(a) The Holder of this Note is entitled, at its option, at any time, to convert all or any amount of the principal face amount
of this Note then outstanding into shares of the Company's common stock (the "Common Stock") at a price ("Conversion
Price") for each share of Common Stock equal to 65% of the lowest trading price
of the Common Stock as re ported on the National Quotations Bureau OTC Market Exchange which the Company's shares
are traded or any exchange upon which the Common Stock may be traded in the future ("Ex change"), for the twenty
prior trading days including the day upon which a Notice of Conversion is received by the Company or its transfer
agent (provided such Notice of Conversion is deliv ered by fax or other electronic method of communication to the Company or its
transfer agent af ter 4 P.M. Eastern Standard or Daylight Savings Time if the Holder
wishes to include the same day closing price). If the shares have not been delivered within
3 business days, the Notice of Conversion may be rescinded. Such conversion shall be effectuated by the Company delivering the
shares of Common Stock to the Holder within 3 business days of receipt by the Company of the Notice of Conversion. Accrued but
unpaid interest shall be subject to conversion. No frac tional shares or scrip representing fractions of shares will be issued
on conversion, but the num ber of shares issuable shall be rounded to the nearest whole share. To the extent the Conversion Price
of the Company's Common Stock closes below the par value per share, the Company will take all steps necessary to solicit the consent
of the stockholders to reduce the par value to the lowest value possible under law. The Company agrees to honor all conversions
submitted pend ing this increase. In the event the Company experiences a DTC "Chill" on its shares, the Con version
Price shall be decreased to 55% instead of 65% while that "Chill" is in effect. In
no event shall the Holder be allowed to effect a conversion if such conversion, along with all other shares of Company
Common Stock beneficially owned by the Holder and its affiliates would ex ceed 9.9% of the outstanding shares of the Common Stock
of the Company. All the terms set forth herein, including but not limited to interest rate, prepayment terms, conversion discount
or lookback period will be adjusted downward (i.e. for the benefit of the Holder) if the Company offers a more favorable conversion
discount (whether via interest, rate 01D or otherwise) or lookback period to another party or otherwise grants any more favorable
terms to any third party than those contained herein while this note is in effect.

(b)              
Interest on any unpaid principal balance of this Note shall be paid at the rate of 8% per annum. Interest shall be paid by the
Company in Common Stock ("Interest Shares"). Holder may, at any time, send in a Notice of Conversion to the Company
for Interest Shares based on the formula provided in Section 4(a) above. The dollar amount converted into Interest Shares shall
be all or a portion of the accrued interest calculated on the unpaid principal balance of this Note to the date of such notice.

	PREPAY DATE	PREPAY AMOUNT
	<61 days	115% of principal plus accrued interest
	61 - 120 days	125% of principal plus accrued interest
	120 - 180 days	135% of principal plus accrued interest

This
Note may not be prepaid after the 1801 day. Such redemption must be closed and funded within 3 days of giving notice of redemption
of the right to redeem shall be null and void.

 

(d)              
Upon (i) a transfer of all or substantially all of the assets of the Company to any person in a single transaction or series of
related transactions, (ii) a reclassification, capital reorganization or other change or exchange of outstanding shares of the
Common Stock, other than a forward or reverse stock split or stock dividend, or (iii) any consolidation or merger of the Company
with or into another person or entity in which the Company is not the surviving entity (other than a merger which is effected
solely to change the jurisdiction of incorporation of the Company and results in a reclassification, conversion or exchange of
outstanding shares of Common Stock solely into shares of Common Stock) (each of items (i), (ii) and (iii) being re ferred to as
a "Sale Event"), then, in each case, the Company shall, upon request of the Holder, redeem this Note in cash for 150%
of the principal amoun4 plus accrued but unpaid interest through the date of redemption, or at the election of the Holder, such
Holder may convert the un paid principal amount of this Note (together with the amount of accrued but unpaid interest) into shares
of Common Stock immediately prior to such Sale Event at the Conversion Price.

(e)              
In case of any Sale Event (not to include a sale of all or substantially all of the Company's assets) in connection with which
this Note is not redeemed or converted, the Company shall cause effective provision to be made so that the Holder of this Note
shall have the right thereafter, by converting this Note, to purchase or convert this Note into the kind and number of shares
of stock or other securities or property (including cash) receivable upon such reclassification, capital reorganization or other
change, consolidation or merger by a holder of the number of shares of Common Stock that could have been purchased upon exercise
of the Note and at the same Conversion Price, as defined in this Note, immediately prior to such Sale Event. The foregoing provisions
shall similarly apply to successive Sale Events. If the considera tion received by the holders
of Common Stock is other than cash, the value shall be as deter mined by the Board of Directors of the Company or successor person
or entity acting in good faith.

 

5.
                 Noprovisionofthis
Note shall alter or impair the obligation of theC ompany, which is absolute and unconditional, to pay the principal of, and interest
on, this Note at the time, place, and rate, and in the form, herein prescribed.

 

6.                 
The Company hereby expressly waives demand and presentment for pay- ment, notice of non-payment, protest, notice of protest, notice
of dishonor, notice of acceleration or intent to accelerate, and diligence in taking any action to collect amounts called for
hereunder and shall be directly and primarily liable for the payment of all sums owing and to be owing hereto.

 

7.                 
The Company agrees to pay all costs and expenses, including reasonable attorneys' fees and expenses, which may be incurred by
the Holder in collecting any amount due under this Note.

 

8.
If one or more of the following described "Events of Default" shall occur:

 

(a)              
The Company shall default in the payment of principal
or interest on this Note or any other note issued to the Holder by the Company; or

 

(b)              
Any of the representations or warranties made
by the Company herein or in any certificate or financial or other written statements heretofore or hereafter furnished by or on
behalf of the Company in connection with the execution and delivery of this Note, or the Se curities Purchase Agreement under
which this note was issued shall be false or misleading in any respect; or

 

(c)              
The Company shall fail to perform or observe,
in any respect, any cove- nant, term, provision, condition, agreement or obligation of the Company under this Note or any other
note issued to the Holder; or

 

(d)              
The Company shall (I) become insolvent; (2) admit
in writing its inability to pay its debts generally as they mature; (3) make an assignment for the benefit of creditors or commence
proceedings for its dissolution; (4) apply for or consent to the appointment of a trus tee, liquidator or receiver for its or
for a substantial part of its property or business; (5) file a peti tion for bankruptcy relief, consent to the filing of such
petition or have filed against it an invol untary petition for bankruptcy relief, all under federal or state laws as applicable;
or

 

(e)              
A trustee, liquidator or receiver shall be appointed
for the Company or for a substantial part of its property or business without its consent and shall not be discharged with in
sixty (60) days after such appointment; or

 

(f)               
Any governmental agency or any court of competent
jurisdiction at the in- stance of any governmental agency shall assume custody or control of the whole or any substan tial portion
of the properties or assets of the Company; or

 

(g)              
One or more money judgments, writs or warrants
of attachment, or similar process, in excess of fifty thousand dollars ($50,000) in the aggregate, shall be entered or filed against
the Company or any of its properties or other assets and shall remain unpaid, unvacated, unbonded or unstayed for a period of
fifteen {15) days or in any event later than five (5) days prior to the date of any proposed sale thereunder; or

 

(h)              
The Company shall have defaulted on or breached
any term of any other note of similar debt instrument into which the Company has entered and failed to cure such de fault within
the appropriate grace period; or

 

(i)               
The Company shall have its Common Stock delisted
from an exchange (including the OTC Market exchange) or, if the Common Stock trades on an exchange, then trad ing in the Common
Stock shall be suspended for more than 10 consecutive days;

 

(j)               
If a majority of the members of the Board of
Directors of the Company on the date hereof are no longer serving as members of the Board;

 

(k)              
The Company shall not deliver to the Holder the
Common Stock pursuant to paragraph 4 herein without restrictive legend within 3 business days of its receipt of a Notice of Conversion;
or

 

(I)          
The Company shall not replenish the reserve set
forth in Section 12, with- in 3 business days of the request of the Holder.

 

(m)            
The Company shall not be "current"
in its filings with the Securities and Exchange Commission; or

 

(n)              
The Company shall lose the "bid" price
for its stock in a market (including the OTC marketplace or other exchange).

Then,
or at any time thereafter, unless cured within 5 days, and in each and every such case, un less such Event of Default shall have
been waived in writing by the Holder (which waiver shall not be deemed to be a waiver of any subsequent default) at the option
of the Holder and in the Holder's sole discretion, the Holder may consider this Note immediately due and payable, with out presentment,
demand, protest or (further) notice of any kind (other than notice of accelera tion), all of which are hereby expressly waived,
anything herein or in any note or other instru ments contained to the contrary notwithstanding, and the Holder may immediately,
and without expiration of any period of grace, enforce any and all of the Holder's rights and remedies provid ed herein or any
other rights or remedies afforded by law. Upon an Event of Default, interest shall accrue at a default interest rate of 24% per
annum or, if such rate is usurious or not permit ted by current law, then at the highest rate of interest permitted by law. In
the event of a breach of Section 8(k) the penalty shall be $250 per day the shares are not issued beginning on the 4th
day after the conversion notice was delivered to the Company. This penalty shall increase to $500 per day beginning on the
10 th day. The penalty for a breach of Section 8(n) shall be an in crease of the outstanding principal amounts by 20%.
Further, if a breach of Section 8(m) occurs or is continuing after the 6 month anniversary of the Note, then the Holder shall
be entitled to use the lowest closing bid price during the delinquency period as a base price for the conversion. For example,
if the lowest closing bid price during the delinquency period is $0.01 per share and the conversion discount is 50% the Holder
may elect to convert future conversions at $0.005 per share.

If
the Holder shall commence an action or proceeding
to enforce any provisions of this Note, in cluding, without limitation, engaging an attorney, then if the Holder prevails in such
action, the Holder shall be reimbursed by the Company for its attorneys' fees and other costs and expenses incurred in
the investigation, preparation and prosecution of such action or proceeding.

 

Make-Whole
for Failure to Deliver Loss. At the Holder's election, if the Company fails for any reason to deliver to the Holder the conversion
shares by the by the 3rd business day following the delivery of a Notice of Conversion to the Company and if the Holder incurs
a Failure to Deliver Loss, then at any time the Holder may provide the Company written notice indicating the amounts payable to
the Holder in respect of the Failure to Deliver Loss and the Company must make the Holder whole as follows:

Failure
to Deliver Loss = [(Highest VWAP price for the 30 trading days on or after the day of exercise) x (Number of conversion shares)]

The
Company must pay the Failure to Deliver Loss by cash payment, and any such cash payment must be made by the third business day
from the time of the Holder's written notice to the Com pany.

9.                 
In case any provision of this Note is held by a court of competent jurisdic- tion to be excessive in scope or otherwise invalid
or unenforceable, such provision shall be ad justed rather than voided, if possible, so that it is enforceable to the maximum
extent possible, and the validity and enforceability of the remaining provisions of this Note will not in any way be affected
or impaired thereby.

10.
Neither this Note nor any term hereof may be amended, waived, dis- charged or terminated other than by a written instrument signed
by the Company and the Holder.

11.             
The Company represents that it is not a "shell" issuer and has never been a "shell" issuer or that if it previously
has been a "shell" issuer that at least 12 months have passed since the Company has reported form 10 type information
indicating it is no longer a "shell issu er. Further. The Company will instruct its counsel to either (i) write a 144 opinion
to allow for salability of the conversion shares or (ii) accept such opinion from Holder's counsel.

12.           
The Company shall issue irrevocable transfer agent instructions reserving 39,968,000 shares of its Common Stock for conversions
under this Note (the "Share Reserve"). Upon full conversion of this Note, any shares remaining in the Share Reserve
shall be cancelled. The Company shall pay all costs associated with issuing and delivering the shares. If such amounts are to
be paid by the Holder, it may deduct such amounts from the Conversion Price. The company should at all times reserve a minimum
of four times the amount of shares required if the note would be fully converted. The Holder may reasonably request increases
from time to time to reserve such amounts. The Company will instruct its transfer agent to provide the out standing share information
to the Holder in connection with its conversions.

The
Company will give the Holder direct notice of any corporate actions, including but not limited to name changes, stock splits,
recapitalizations etc. This notice shall be given to the Holder as soon as possible under law.

14.             
If it shall be found that any interest or other amount deemed interest due hereunder violates the applicable law governing usury,
the applicable provision shall automatically be revised to equal the maximum rate of interest or other amount deemed interest
permitted under applicable law. The Company covenants (to the extent that it may lawfully do so) that it will not seek to claim
or take advantage of any law that would prohibit or forgive the Company from paying all or a portion of the principal or interest
on this Note.

15.             
This Note shall be governed by and construed in accordance with the laws of New York applicable to contracts made and wholly to
be performed within the State of New York and shall be binding upon the successors and assigns of each party hereto. The Holder
and the Company hereby mutually waive trial by jury and consent to exclusive jurisdiction and venue in the courts of the State
of New York or in the Federal courts sitting in the county or city of New York. This Agreement may be executed in counterparts,
and the facsimile transmission of an executed counterpart to this Agreement shall be effective as an original.

    	 	1	 

     

    

IN
WITNESS WHEREOF, the Company has caused this Note to be duly execut ed by an officer thereunto duly authorized.

 

		 	REGEN BIOPHARMA, INC.
	 	 	 
	Dated: October 4, 2018	 	/s/ David Koos
	 	 	Title: David Koos, Chairman & CEO
	 	 	 

 

    	 	2	 

     

    

EXHIBIT
A

 

NOTICE
OF CONVERSION

 

(To
be Executed by the Registered Holder in order to Convert the Note)

 

The
undersigned hereby irrevocably elects to convert $ of the above Note into
Shares of Common Stock of Regen Biophanna, Inc. ("Shares") according to the conditions set forth in such
Note, as of the date written below.

If
Shares are to be issued in the name of a person other than the undersigned, the undersigned will pay all transfer and other taxes
and charges payable with respect thereto.

	Date of Conversion:
	Applicable Conversion Price:
	Signature:
	[Print
    Name of Holder and Title of Signer]
	Address:
	 
	SSN or EIN:
	Shares are to be registered in the following
    name:
	 
	Name:
	Address:
	Tel:
	Fax:
	SSN or EIN:
	 
	Shares are to be sent or delivered to the following
    account:
	 
	Account Name:
	Address:

    	 	3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00291-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00291-of-00352.parquet"}]]